After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
CDMO belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $8.15 and fluctuated between $8.30 as its day high and $7.95 as its day low. The current market capitalization of Avid Bioservices Inc is $515.41M. A total of 0.91 million shares were traded on the day, compared to an average of 1.51M shares.
Insider Activity
Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, CDMO has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 55 BUYs and 38 SELLs from insiders. Insiders purchased 335,278 shares during that period but sold 176,698.
In the most recent transaction, Kwietniak Matthew R. sold 274 shares of CDMO for 6.77 per share on Jan 12. After the transaction, the Chief Commercial Officer now owns 19,829 company shares. In a previous transaction on Jan 10, Hart Daniel R sold 2,408 shares at 6.17 per share. CDMO shares that Chief Financial Officer owns now total 79,305.
Among the insiders who sold shares, Ziebell Mark R disposed of 1,346 shares on Jan 10 at a per-share price of $6.17. This resulted in the V. P., General Counsel holding 63,269 shares of CDMO after the transaction. In another insider transaction, Kwietniak Matthew R. sold 1,060 shares at $6.17 per share on Jan 10. Company shares held by the Chief Commercial Officer now total 19,434.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for CDMO in the last 3 months, the mean price target is $13.00 with high estimates of $16.00 and low estimates of $7.00. In terms of 52-week highs and lows, CDMO has a high of $21.05 and a low of $4.07.
As of this writing, CDMO has an earnings estimate of -$0.05 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of -$0.03 per share and a lower estimate of -$0.07.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. CDMO’s latest balance sheet shows that the firm has $126.17M in Cash & Short Term Investments as of fiscal 2022. There were $182.53M in debt and $75.76M in liabilities at the time. Its Book Value Per Share was $2.90, while its Total Shareholder’s Equity was $174.53M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CDMO is Buy with a score of 4.40.
